Showing 7231-7240 of 7742 results for "".
- ASDS Honors Legacy of Dr. Fredric Brandthttps://practicaldermatology.com/news/asds-honors-legacy-of-dr-fredric-brandt/2458958/The American Society for Dermatologic Surgery is paying tribute to the late cosmetic dermatologist Fredric S. Brandt, MD by setting up two memorial funds in his honor. Dr. Brandt, an ASDS member since 1982, died earlier this month at age 65 at his Florida home. The ASDS said the funds are
- Benzac Acne Solutions Premieres “Insta-Dramedy” Webserieshttps://practicaldermatology.com/news/benzac-acne-solutions-premieres-insta-dramedy-webseries/2458955/Galderma Laboratories, L.P launched its first webisode series, “The Benzacs,” a teen insta-dramedy told through 15-second Instagram videos and more than 80 images and short videos. The webseries features the new over-the-counter (OTC) acne treatment Benzac® Acne Solutions, which c
- Merck's Pembrolizumab Demonstrates Positive Results in Phase III Study for Advanced Melanomahttps://practicaldermatology.com/news/mercks-pembrolizumab-demonstrates-positive-results-in-phase-iii-study-for-advanced-melanoma/2458959/Merck announced results from the randomized, pivotal Phase III study, KEYNOTE-006, in the treatment of unresectable advanced melanoma. In the study, pembrolizumab was statistically superior to ipilimumab for progression-free survival (PFS), overall survival (OS), and overall response rate (ORR).
- DEKA Receives Additional FDA Clearance for its Synchro REPLA:Y Laser Systemshttps://practicaldermatology.com/news/deka-receives-additional-fda-clearance-its-synchro-replay-laser-systems/2458960/DEKA M.E.L.A received additional FDA clearance for its Synchro REPLA:Y® family of Laser Systems, allowing for Maximum Power of 180W and a 24mm spot size, the largest available in the industry. The Synchro REPLA:Y® family of Laser Systems consists of three aesthetic workstati
- RXi Pharmaceuticals Receives FDA Orphan Drug Designation for Samcyprone for Melanomahttps://practicaldermatology.com/news/rxi-pharmaceuticals-receives-fda-orphan-drug-designation-for-samcyprone-for-melanoma/2458964/The FDA granted RXi Pharmaceuticals Corporation Orphan Drug Designation of its second clinical candidate, Samcyprone™, for the treatment of malignant melanoma Stage IIb to IV. A number of patients with Stage IIb to IV malignant melanoma develop cutaneous metastases. Samcyprone™ is bei
- Foamix Pharmaceuticals Announces Upsizing and Pricing of Its Public Offeringhttps://practicaldermatology.com/news/foamix-pharmaceuticals-announces-upsizing-and-pricing-of-its-public-offering/2458968/Foamix Pharmaceuticals Ltd. (Nasdaq:FOMX), a specialty pharmaceutical company focused on developing topical foams to address unmet needs in dermatology, today announced the pricing of an upsized public offering of 6,451,612 ordinary shares at a price to the public of $9.30 per share. In addition,
- FixMySkin Unveils New Lookhttps://practicaldermatology.com/news/fixmyskin-unveils-new-look/2458974/FixMySkin Healing Balms with 1% Hydrocortisone have a new look with the same great formula. Now available in environmentally friendly packaging, these balms come in two convenient sizes for the lips and body. Th
- CareCredit Hosts Free Webinar on How to Host Successful Patient Eventshttps://practicaldermatology.com/news/carecredit-hosts-free-webinar-on-how-to-host-successful-patients-events/2458975/CareCredit will be sponsoring a free webinar to all aesthetic providers on how to host successful patient events. The webinar, How to Host Events That Bring Real Results: The Dos, Don’ts, and Definites, will be presented by Karen Zupko, President of Karen Zupko & Associate
- Novan Secures $50 Million Private Financinghttps://practicaldermatology.com/news/novan-secures-50-million-private-financing/2458973/Novan Therapeutics, a clinical-stage biotechnology company focused on advancing innovation in dermatology via nitric oxide therapies, today announced that it has secured $50 million in an oversubscribed private financing. New investor Malin Corporation Plc. (MLC: ISE) functioned as the cornerston
- New Officers Assume Roles with the American Academy of Dermatologyhttps://practicaldermatology.com/news/new-officers-assume-roles-with-the-american-academy-of-dermatology/2458976/Mark Lebwohl, MD, FAAD, a dermatologist in New York City, took office as president of the American Academy of Dermatology (AAD). Timothy G. Berger, MD, FAAD, a dermatologist in San Francisco, also assumed his position as vice president of the AAD. Drs. Lebwohl and Berger assumed office at the con